2-(dec-9-enyl)-3-ethyloxazolidine

ID: ALA4276900

Chembl Id: CHEMBL4276900

PubChem CID: 117063768

Max Phase: Preclinical

Molecular Formula: C15H29NO

Molecular Weight: 239.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CCCCCCCCCC1OCCN1CC

Standard InChI:  InChI=1S/C15H29NO/c1-3-5-6-7-8-9-10-11-12-15-16(4-2)13-14-17-15/h3,15H,1,4-14H2,2H3

Standard InChI Key:  JAVMQJKTKNYVDO-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2009 (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 239.40Molecular Weight (Monoisotopic): 239.2249AlogP: 3.97#Rotatable Bonds: 10
Polar Surface Area: 12.47Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.68CX LogP: 4.56CX LogD: 4.48
Aromatic Rings: Heavy Atoms: 17QED Weighted: 0.42Np Likeness Score: 0.47

References

1. Uko NE, Güner OF, Barnett LMA, Matesic DF, Bowen JP..  (2018)  Discovery and biological activity of computer-assisted drug designed Akt pathway inhibitors.,  28  (19): [PMID:30143420] [10.1016/j.bmcl.2018.08.006]

Source